Ciprofloxacin HCl

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

55 API Suppliers, 23 USDMF, 17 CEP/COS, 3 JDMF, 11 EU WC, 19 KDMF, 21 NDC API, 22 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

211 FDF Dossiers, 86 FDA Orange Book, 39 Europe, 37 Canada, 2 South Africa, 47 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION/DROPS;OPHTHALMIC - EQ 0.3% BASE, OINTMENT;OPHTHALMIC - EQ 0.3% BASE, SUSPENSION/DROPS;OTIC - EQ 0.2% BASE;1%

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 17 SPI Pharma, 2 Seqens, 7 DKSH, 2 Jai Radhe Sales, 8 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 14 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 15 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 34 BASF, 2 Clariant, 11 Corel Pharma Chem, 1 Curia, 6 DFE Pharma, 4 Finar, 13 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 33 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 27 Roquette, 15 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

96 Fillers, Diluents & Binders, 57 Coating Systems & Additives, 49 Direct Compression, 42 Disintegrants & Superdisintegrants, 39 Solubilizers, 34 Controlled & Modified Release, 33 Granulation, 33 Thickeners and Stabilizers, 29 Parenteral, 26 Topical, 24 Taste Masking, 22 Lubricants & Glidants, 21 Co-Processed Excipients, 20 Film Formers & Plasticizers, 18 Chewable & Orodispersible Aids, 10 Emulsifying Agents, 8 API Stability Enhancers, 6 Surfactant & Foaming Agents, 5 Empty Capsules, 5 Coloring Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules

DIGITAL CONTENT

8 DATA COMPILATION #PharmaFlow, 15 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 6 Finished Drug Prices

MARKET PLACE

42 APIs, 3 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Patents, 10 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 1 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20805 / DOSAGE - SUSPENSION/DROPS;OTIC - EQ 0.2% BASE;1%

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
CIPROFLOXACIN HYDROCHLORIDE(UNII: 4BA73M5E37) (CIPROFLOXACIN - UNII:5E8K9I0O4U)	CIPROFLOXACIN	2mg in 1
HYDROCORTISONE(UNII: WI4X0X7BPJ) (HYDROCORTISONE - UNII:WI4X0X7BPJ)	HYDROCORTISONE	10mg in 1

Inactive Ingredients

Ingredient Name	Alcon Laboratories, Inc.
ACETIC ACID(Q40Q9N063P)
BENZYL ALCOHOL(LKG8494WBH)
HYDROCHLORIC ACID(QTT17582CB)
LECITHIN, SOYBEAN(1DI56QDM62)
POLYSORBATE 20(7T1F30V5YH)
POLYVINYL ALCOHOL(532B59J990)
SODIUM ACETATE(4550K0SC9B)
SODIUM CHLORIDE(451W47IQ8X)
SODIUM HYDROXIDE(55X04QC32I)
WATER(059QF0KO0R)

Drug Product Composition: Ciprofloxacin HCl